Homooligomerization of the ABC-transporter 3 and its functional significance

S. Frixel, E. Kaltenborn, A. S. Lotz-Havla, S. W. Gersting, R. Zarbock, M. Griese (Munich, Germany)

Source: International Congress 2014 – ILDs 3
Session: ILDs 3
Session type: Thematic Poster Session
Number: 790
Disease area: Interstitial lung diseases, Paediatric lung diseases

Congress or journal article abstract

Abstract

Background and aim: ABCA3 is a surfactant lipid transporter in the limiting membrane of lamellar bodies in alveolar type II cells. Mutations in the ABCA3 gene cause respiratory distress syndrome in newborns and chronic interstitial lung disease in children and adults. ABCA3 belongs to the class of full ABC-transporters, which are supposed to be functional in their monomeric forms. Though other family members e.g. ABCA1 and ABCC7 have been shown to function as oligomers, the oligomerization state of ABCA3 remains to be elucidated.Methods: Oligomerization of ABCA3 was investigated in cell lysates and crude membrane preparations from transiently and stably transfected HEK293 cells using blue native PAGE (BN-PAGE), gel filtration and co-immunoprecipitation. Additionally, homooliomerization was examined in vivo in cells using bioluminescence resonance energy transfer (BRET).Results: Using BN-PAGE and gel filtration, methods that separate proteins in their native state according to their molecular size, we could show that non-denatured ABCA3 exists in different oligomeric forms, such as monomers, dimers, tetramers and even higher oligomers. Homooligomerization of ABCA3-wildtype was shown via co-immunoprecipitation of HA- and YFP-tagged ABCA3. Oligomerization could be verified in vivo by detecting positive interactions using BRET.Conclusion: Besides its monomeric state, ABCA3 was detected in additional oligomeric forms. We therefore suggest transporter oligomerization as a central mechanism for ABCA3 function. Insights into the fundamentals of the transport process will provide a better understanding of ABCA3-related diseases and enable the analysis of patient mutations and its interactions.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Frixel, E. Kaltenborn, A. S. Lotz-Havla, S. W. Gersting, R. Zarbock, M. Griese (Munich, Germany). Homooligomerization of the ABC-transporter 3 and its functional significance. Eur Respir J 2014; 44: Suppl. 58, 790

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Outcome of acute drug-induced pneumonias in ICU
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013


Expression of water and ion channels proteins in acute respiratory distress syndrome from different etiologies
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014

Dysfunction of oxidized pulmonary surfactant is cholesterol-dependent
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013


Markers of poor outcome in patients with acute hypoxemic respiratory failure
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014

Essential oils reduced lung inflammation in a model of acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014

Septic pulmonary embolisms as a cause of acute respiratory distress syndrome
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016


Assessing regional PEEP-related airway opening and dilatation in ARDS patients
Source: International Congress 2015 – Acute critical care: mechanical ventilation: how to limit the damage
Year: 2015

Radiologic features of lung involvement in young patients with viral pneumonia
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016

Lung recruitment maneuver with and without nebulized albuterol for acute lung injury
Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning
Year: 2014


Long-term effects of nebulized LPS in a mouse model of acute lung injury (ALI)
Source: International Congress 2014 – ILDs 6
Year: 2014

Lung inflammation was attenuated by sakuranetin treatment in a model of acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014

Methotrexate reduces acute lung injury in a murine model of sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016


LATE-BREAKING ABSTRACT: Trasplantation of alveolar type II cells in experimental Acute Lung Injury
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014

Acute respiratory distress syndrome in patients admitted for community-acquired pneumonia
Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning
Year: 2014


Effects of nebulized heparin in a rat-model of endotoxemia-induced lung injury
Source: International Congress 2014 – Critical illness and therapeutic interventions
Year: 2014


Clinical and microbiological characteristics and outcome of ARDS in India
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016


Morbi-mortality evaluation in prolonged prone positioning during severe ARDS
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015

Obesity is associated with airspace lipid dysregulation
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016

Lung protective ventilator settings for lung transplantation? The Harefield experience
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Amphetamine induced eosinophilic pneumonia: A case report
Source: International Congress 2014 – ILDs 6
Year: 2014